Antibe Therapeutics Inc.
ATE
Rang în acțiuni
#31923
Antibe Therapeutics Inc. is a biotechnology company specializing in the... Antibe Therapeutics Inc. is a biotechnology company specializing in the development of groundbreaking therapeutics and medical devices. Operating internationally, including Canada, Europe, and the United States, their work targets pain, inflammation, and regenerative medicine. A key focus is developing drugs designed to prevent the gastrointestinal harm and bleeding often caused by non-steroidal anti-inflammatory drugs. Their leading candidate, Otenaproxesul, is a hydrogen sulfide-releasing derivative of naproxen. This compound has already finished a Phase 2B gastrointestinal safety study and is being investigated for a range of indications, such as post-operative pain, migraines, dysmenorrhea, traumatic injuries, dental pain, and gout. Additionally, their product portfolio features ATB-352, currently in preclinical development for managing acute pain. The company, incorporated in 2009, is headquartered in Toronto, Canada.
Preț acțiune
$0.21483059
Ultima sincronizare: 2024-05-07
Capitalizare de piață
$11.13M
Schimbare (1 zi)
0.34%
Schimbare (1 an)
-0.36%
Țară
CA
Tranzacționează Antibe Therapeutics Inc. (ATE)
Categorie
Healthcare
Capitalizarea de piață a Antibe Therapeutics Inc.(ATE)
Capitalizare de piață: $11.13M
În anul October 2026, Antibe Therapeutics Inc. are o capitalizare de piață de $11.13M. Acest lucru face ca Antibe Therapeutics Inc. să fie a 31923rd-a cea mai valoroasă companie din lume, conform datelor noastre. Capitalizarea bursieră reprezintă valoarea totală de piață a acțiunilor în circulație ale unei companii listate și este utilizată frecvent pentru a măsura valoarea unei companii.
Istoricul capitalizării de piață a Antibe Therapeutics Inc. din 2014 până în 2026
ATE în comparație cu top 5 cele mai populare stocks
| Prețul pentru ATE | Activul B | Capitalizarea de piață a B | Rezultate | |
|---|---|---|---|---|
$97,474.03
$11.43M
|
$5.167T | +45,210,489.55% | ||
|
$94,601.69
$11.43M
|
$5.015T | +43,878,236.98% | ||
|
$77,503.28
$11.43M
|
$4.108T | +35,947,616.06% | ||
|
$73,607.77
$11.43M
|
$3.902T | +34,140,794.84% | ||
|
$50,735.45
$11.43M
|
$2.689T | +23,532,114.43% |
